343 related articles for article (PubMed ID: 37304140)
1. Patient-derived organoids of lung cancer based on organoids-on-a-chip: enhancing clinical and translational applications.
Zeng X; Ma Q; Li XK; You LT; Li J; Fu X; You FM; Ren YF
Front Bioeng Biotechnol; 2023; 11():1205157. PubMed ID: 37304140
[TBL] [Abstract][Full Text] [Related]
2. Ex vivo drug testing of patient-derived lung organoids to predict treatment responses for personalized medicine.
Taverna JA; Hung CN; Williams M; Williams R; Chen M; Kamali S; Sambandam V; Hsiang-Ling Chiu C; Osmulski PA; Gaczynska ME; DeArmond DT; Gaspard C; Mancini M; Kusi M; Pandya AN; Song L; Jin L; Schiavini P; Chen CL
Lung Cancer; 2024 Apr; 190():107533. PubMed ID: 38520909
[TBL] [Abstract][Full Text] [Related]
3. Development of Patient-Derived Gastric Cancer Organoids from Endoscopic Biopsies and Surgical Tissues.
Gao M; Lin M; Rao M; Thompson H; Hirai K; Choi M; Georgakis GV; Sasson AR; Bucobo JC; Tzimas D; D'Souza LS; Buscaglia JM; Davis J; Shroyer KR; Li J; Powers S; Kim J
Ann Surg Oncol; 2018 Sep; 25(9):2767-2775. PubMed ID: 30003451
[TBL] [Abstract][Full Text] [Related]
4. Genomic characteristics and drug screening among organoids derived from non-small cell lung cancer patients.
Chen JH; Chu XP; Zhang JT; Nie Q; Tang WF; Su J; Yan HH; Zheng HP; Chen ZX; Chen X; Song MM; Yi X; Li PS; Guan YF; Li G; Deng CX; Rosell R; Wu YL; Zhong WZ
Thorac Cancer; 2020 Aug; 11(8):2279-2290. PubMed ID: 32633046
[TBL] [Abstract][Full Text] [Related]
5. Tumor organoids: synergistic applications, current challenges, and future prospects in cancer therapy.
Qu J; Kalyani FS; Liu L; Cheng T; Chen L
Cancer Commun (Lond); 2021 Dec; 41(12):1331-1353. PubMed ID: 34713636
[TBL] [Abstract][Full Text] [Related]
6. Patient Derived Organoids (PDOs), Extracellular Matrix (ECM), Tumor Microenvironment (TME) and Drug Screening: State of the Art and Clinical Implications of Ovarian Cancer Organoids in the Era of Precision Medicine.
Spagnol G; Sensi F; De Tommasi O; Marchetti M; Bonaldo G; Xhindoli L; Noventa M; Agostini M; Tozzi R; Saccardi C
Cancers (Basel); 2023 Mar; 15(7):. PubMed ID: 37046719
[TBL] [Abstract][Full Text] [Related]
7. Cancer organoids: A platform in basic and translational research.
Ma X; Wang Q; Li G; Li H; Xu S; Pang D
Genes Dis; 2024 Mar; 11(2):614-632. PubMed ID: 37692477
[TBL] [Abstract][Full Text] [Related]
8. Organoid technology and applications in lung diseases: Models, mechanism research and therapy opportunities.
Chen J; Na F
Front Bioeng Biotechnol; 2022; 10():1066869. PubMed ID: 36568297
[TBL] [Abstract][Full Text] [Related]
9. Patient-derived organoids of non-small cells lung cancer and their application for drug screening.
Li YF; Gao Y; Liang BW; Cao XQ; Sun ZJ; Yu JH; Liu ZD; Han Y
Neoplasma; 2020 Mar; 67(2):430-437. PubMed ID: 31973535
[TBL] [Abstract][Full Text] [Related]
10. Gastrointestinal cancer organoids-applications in basic and translational cancer research.
Seidlitz T; Stange DE
Exp Mol Med; 2021 Oct; 53(10):1459-1470. PubMed ID: 34663939
[TBL] [Abstract][Full Text] [Related]
11. Patient- and xenograft-derived organoids recapitulate pediatric brain tumor features and patient treatments.
Lago C; Federico A; Leva G; Mack NL; Schwalm B; Ballabio C; Gianesello M; Abballe L; Giovannoni I; Reddel S; Rossi S; Leone N; Carai A; Mastronuzzi A; Bisio A; Soldano A; Quintarelli C; Locatelli F; Kool M; Miele E; Tiberi L
EMBO Mol Med; 2023 Dec; 15(12):e18199. PubMed ID: 38037472
[TBL] [Abstract][Full Text] [Related]
12. Establishment of Human Pituitary Neuroendocrine Tumor Derived Organoid and Its Pilot Application for Drug Screening.
Cui R; Duan H; Hu W; Li C; Zhong S; Liang L; Chen S; Hu H; He Z; Wang Z; Guo X; Chen Z; Xu C; Zhu Y; Chen Y; Sai K; Yang Q; Guo C; Mou Y; Jiang X
J Clin Endocrinol Metab; 2024 Apr; ():. PubMed ID: 38656317
[TBL] [Abstract][Full Text] [Related]
13. Patient-derived functional organoids as a personalized approach for drug screening against hepatobiliary cancers.
Li L; Selaru FM
Adv Cancer Res; 2022; 156():319-341. PubMed ID: 35961704
[TBL] [Abstract][Full Text] [Related]
14. Applications of lung cancer organoids in precision medicine: from bench to bedside.
Li H; Chen Z; Chen N; Fan Y; Xu Y; Xu X
Cell Commun Signal; 2023 Dec; 21(1):350. PubMed ID: 38057851
[TBL] [Abstract][Full Text] [Related]
15. Organoids derived from metastatic cancers: Present and future.
Zheng X; Zhang X; Yu S
Heliyon; 2024 May; 10(9):e30457. PubMed ID: 38720734
[TBL] [Abstract][Full Text] [Related]
16. Lung cancer organoids: models for preclinical research and precision medicine.
Liu Y; Zhou Y; Chen P
Front Oncol; 2023; 13():1293441. PubMed ID: 37941550
[TBL] [Abstract][Full Text] [Related]
17. Progress and perspective of organoid technology in cancer-related translational medicine.
Lin Y; Jiang L; He Q; Yuan M; Cao J
Biomed Pharmacother; 2022 May; 149():112869. PubMed ID: 35358798
[TBL] [Abstract][Full Text] [Related]
18. Patient-Derived Organoids as Therapy Screening Platforms in Cancer Patients.
Khorsandi D; Yang JW; Foster S; Khosravi S; Hosseinzadeh Kouchehbaghi N; Zarei F; Lee YB; Runa F; Gangrade A; Voskanian L; Adnan D; Zhu Y; Wang Z; Jucaud V; Dokmeci MR; Shen X; Bishehsari F; Kelber JA; Khademhosseini A; de Barros NR
Adv Healthc Mater; 2024 Feb; ():e2302331. PubMed ID: 38359321
[TBL] [Abstract][Full Text] [Related]
19. Patient-derived pancreatic cancer-on-a-chip recapitulates the tumor microenvironment.
Haque MR; Wessel CR; Leary DD; Wang C; Bhushan A; Bishehsari F
Microsyst Nanoeng; 2022; 8():36. PubMed ID: 35450328
[TBL] [Abstract][Full Text] [Related]
20. Patient-derived organoids as a platform for drug screening in metastatic colorectal cancer.
He X; Jiang Y; Zhang L; Li Y; Hu X; Hua G; Cai S; Mo S; Peng J
Front Bioeng Biotechnol; 2023; 11():1190637. PubMed ID: 37284236
[No Abstract] [Full Text] [Related]
[Next] [New Search]